EDAP TMS, a provider of robotic energy-based therapies, has published the full results from the HIFI study in the prestigious, peer-reviewed journal, European Urology, which has the highest impact factor amongst scientific journals focused in urology.
The study evaluated HIFU versus radical prostatectomy (RP) as a first line treatment of localized prostate cancer. The paper is entitled “Whole-gland or Subtotal High-intensity Focused Ultrasound Versus Radical Prostatectomy: The Prospective, Noninferiority, Nonrandomized, HIFI Trial”, and is authored by Dr Guillaume Ploussard from Department of Urology, UROSUD, Clinique La Croix du Sud, France.
Professor Pascal Rischmann, principal investigator of the HIFI trial and senior author of the publication, says: “The publication of the HIFI study in European Urology will importantly serve to increase awareness amongst the global urology and patient community on how robotic HIFU technology is rapidly changing the treatment paradigm for patients with localized, early-stage prostate cancer. [Read more…] about EDAP TMS publishes results of cancer treatment through robotic system
